At the Meeting on the Med 2021 Conference, CEO & Co-Founder of Precision Medicine Group Mark Clein gave an informative presentation highlighting Precision ADVANCE, the cell & gene therapy collective™, and how it aligns with our mission to help bring life-changing therapies to those that need them the most.
Congratulations to Richard Macaulay on his well-attended presentation “The New SMC-Ultra-Orphan Pathway: HTA Best Practice for Very Rare Diseases?” at Virtual ISPOR 2021. Did you miss Richard’s presentation?
Clare Sarvary Fourrier, SVP of Operational Strategy (EU) for Precision for Medicine moderates this panel discussion with industry experts to share perspectives on the current state of the cell and gene therapy industry and provide key insights in shortening time-to-market for advanced therapies.
Attending Virtual ISPOR 2021 May 17-20? PRECISIONadvisors and PRECISIONheor will be attending with multiple posters, presentations, and workshops. Three posters and one presentation will have a special focus on Orphan diseases. Stay tuned for valuable insights from our experts that you won’t want to miss!
Did you miss PRECISIONadvisor’s Richard Macaulay present “The Future of Reimbursement for Cell & Gene Therapies” at World EPA Congress 2021? Don’t miss great insights about cell & gene therapy reimbursement challenges.
For more information, or to learn how to change your cookies preferences, please click here.